Structure-based design of potent CDK4 selective inhibitor.

被引：0

作者：

Honma, T ^{[1
]}

Hayashi, K ^{[1
]}

Kawanishi, N ^{[1
]}

Yoshizumi, T ^{[1
]}

Hashimoto, N ^{[1
]}

Sugimoto, T ^{[1
]}

Nakamura, K ^{[1
]}

Takaki, T ^{[1
]}

Machida, T ^{[1
]}

Fukasawa, K ^{[1
]}

Hirai, H ^{[1
]}

Iwama, T ^{[1
]}

Ikeura, C ^{[1
]}

Ikuta, M ^{[1
]}

Kamata, K ^{[1
]}

Suzuki-Takahashi, I ^{[1
]}

Hayama, T ^{[1
]}

机构：

[1] Banyu Pharmaceut Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

136-MEDI

引用

页码：U24 / U24

页数：1

共 50 条

[1] Structure-based design of highly potent and selective Cdk4 inhibitors.
Honma, T
Hayashi, K
Yoshizumi, T
Ikeura, C
Ikuta, M
Suzuki-Takahashi, I
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U437 - U438
[2] Discovery of PF-07220060, a potent and selective CDK4 inhibitor
Anders, Lars
Gallego, Gary
CANCER RESEARCH, 2024, 84 (07)
[3] Structure-based optimization of olomoucine, a CDK1/2 inhibitor.
Furet, P
Imbach, P
Capraro, HG
Ruetz, S
Meyer, T
Zimmermann, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U267 - U267
[4] Structure-based generation of a new class of potent Cdk4 inhibitors:: New de novo design strategy and library design
Honma, T
Hayashi, K
Aoyama, T
Hashimoto, N
Machida, T
Fukasawa, K
Iwama, T
Ikeura, C
Ikuta, M
Suzuki-Takahashi, I
Iwasawa, Y
Hayama, T
Nishimura, S
Morishima, H
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (26) : 4615 - 4627
[5] Characterization of a novel potent and selective CDK4/6 inhibitor and a resistance mechanism
Dai, Kang
Li, Cong
Liang, Lingming
Rong, Minging
Orf, Jessica
Keegan, Kathy
Li, Zhihong
Fu, Jiasheng
Ma, Ji
Carlson, Tim
McGee, Larry
Medina, Julio
Kamb, Alexander
Wickramasinghe, Dineli
CANCER RESEARCH, 2012, 72
[6] Structure-based design of a potent and selective peptide inhibitor of caspase-3
Yoshimori, A
Takasawa, R
Sakai, J
Kobayashi, T
Sunaga, S
Tanuma, SI
FEBS JOURNAL, 2005, 272 : 523 - 523
[7] Discovery of novel and selective CDK4/6 inhibitors by pharmacophore and structure-based virtual screening
Yuan, Kai
Min, Wenjian
Wang, Xiao
Li, Jiaxing
Kuang, Wenbin
Zhang, Fang
Xie, Shengnan
Yang, Peng
FUTURE MEDICINAL CHEMISTRY, 2020, 12 (12) : 1121 - 1136
[8] Structure-based design of a potent chimeric thrombin inhibitor
Morenweiser, R
Auerswald, EA
vandeLocht, A
Fritz, H
Sturzebecher, J
Stubbs, MT
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) : 19938 - 19942
[9] Structure-Based Design of A-1293102, a Potent and Selective BCL-XL Inhibitor
Tao, Zhi-Fu
Wang, Xilu
Chen, Jun
Ingram, Justin P.
Jin, Sha
Judge, Russell A.
Kovar, Peter J.
Park, Chang
Sun, Chaohong
Wakefield, Brian D.
Zhou, Li
Zhang, Haichao
Elmore, Steven W.
Phillips, Darren C.
Judd, Andrew S.
Leverson, Joel D.
Souers, Andrew J.
ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (06): : 1011 - 1016
[10] Design, synthesis and biological assessment of novel CDK4 inhibitor with potent anticancer activity
Li, Yongtao
Du, Renle
Nie, Yongwei
Wang, Tianqi
Ma, Yakun
Fan, Yan
BIOORGANIC CHEMISTRY, 2021, 109

← 1 2 3 4 5 →